171 – 180 of 274
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2003
-
Mark
Activated protein C resistance (FVLeiden) and thrombosis: factor V mutations causing hypercoagulable states
(
- Contribution to journal › Scientific review
-
Mark
CCP1-4 of the C4b-binding protein alpha-chain are required for factor I mediated cleavage of complement factor C3b.
(
- Contribution to journal › Article
-
Mark
Reactions to awareness of activated protein C resistance carriership: a descriptive study of 270 women.
(
- Contribution to journal › Article
-
Mark
Prevention of thrombosis following deep arterial injury in rats by bovine activated protein C requiring co-administration of bovine protein S.
(
- Contribution to journal › Article
-
Mark
Role of CCP2 of the C4b-binding protein beta-chain in protein S binding evaluated by mutagenesis and monoclonal antibodies.
(
- Contribution to journal › Article
-
Mark
Factor V Leiden in pregnancies complicated by placental abruption
(
- Contribution to journal › Article
-
Mark
Gla-domain mutated human protein C exhibiting enhanced anticoagulant activity and increased phospholipid binding.
(
- Contribution to journal › Article
-
Mark
Low-molecular-weight heparin (dalteparin) effectively prevents thrombosis in a rat model of deep arterial injury.
(
- Contribution to journal › Article
-
Mark
Factor V New Brunswick: Ala221Val associated with FV deficiency reproduced in vitro and functionally characterized.
(
- Contribution to journal › Article
-
Mark
Importance of protein S and phospholipid for activated protein C-mediated cleavages in factor Va.
(
- Contribution to journal › Article